Loading…
Substance P ameliorates tumor necrosis factor‐alpha‐induced endothelial cell dysfunction by regulating eNOS expression in vitro
Objective The aim of this study was to explore the beneficial effects of SP on NO production and inflammation‐induced vascular endothelium cell death. Methods To mimic the inflammatory environment, TNF‐α was treated with HUVECs, and SP was added prior to TNF‐α to determine its protective effect. WST...
Saved in:
Published in: | Microcirculation (New York, N.Y. 1994) N.Y. 1994), 2018-04, Vol.25 (3), p.e12443-n/a |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3573-4568c4e6b750ca68d2b11e69f95645967ff2fc82a05acf6aa47f7940f5b4ede43 |
---|---|
cites | cdi_FETCH-LOGICAL-c3573-4568c4e6b750ca68d2b11e69f95645967ff2fc82a05acf6aa47f7940f5b4ede43 |
container_end_page | n/a |
container_issue | 3 |
container_start_page | e12443 |
container_title | Microcirculation (New York, N.Y. 1994) |
container_volume | 25 |
creator | Piao, Jiyuan Hong, Hyun Sook Son, Youngsook |
description | Objective
The aim of this study was to explore the beneficial effects of SP on NO production and inflammation‐induced vascular endothelium cell death.
Methods
To mimic the inflammatory environment, TNF‐α was treated with HUVECs, and SP was added prior to TNF‐α to determine its protective effect. WST‐1 assay was performed to detect cell viability. NO level in conditioned medium was measured by Griess Reagent System. The protein level of cleaved caspase‐3, eNOS, and phosphorylated Akt was detected by Western blot analysis.
Results
TNF‐α declined endothelial cell viability by downregulating Akt and NO production. TNF‐α‐induced cell death was reliably restored by NO, confirming the requirement of NO for cell survival. By contrast, pretreatment of SP attenuated TNF‐α‐induced cellular apoptosis, accompanied by an increase in the phosphorylation of Akt, eNOS expression, and NO production. Blockage of NK‐1R, phosphorylated Akt or eNOS by CP‐96345, A6730, or L‐NAME entirely eliminated the effect of SP.
Conclusions
SP can protect the vascular endothelium against inflammation‐induced damage through modulation of the Akt/eNOS/NO signaling pathway. |
doi_str_mv | 10.1111/micc.12443 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1999194323</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1999194323</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3573-4568c4e6b750ca68d2b11e69f95645967ff2fc82a05acf6aa47f7940f5b4ede43</originalsourceid><addsrcrecordid>eNp9kc9uFDEMxiMEoqVw4QFQJC6o0pYkk8lMjmhFS6VCkQrnKJNx2lQzyZI_bfdWiRfgGXkSMmzhwAFfbMk_f7L9IfSSkiNa4-3sjDmijPPmEdqnLZervqPyca1J16yk6Ps99Cyla0JI3zP5FO0xySsv5T76flGGlLU3gD9jPcPkQtQZEs5lDhF7MDEkl7DVJof48_6HnjZXumbnx2JgxODHkK_qnJ6wgWnC4zbZ4k12weNhiyNclkln5y8xfDq_wHC3iZDS0nUe37gcw3P0xOopwYuHfIC-Hr__sv6wOjs_OV2_O1uZpq2H8Fb0hoMYupYYLfqRDZSCkFa2grdSdNYya3qmSauNFVrzznaSE9sOHEbgzQF6s9PdxPCtQMpqdmnZWXsIJSkqpaSSN6yp6Ot_0OtQoq_bKUZYIyTtBKvU4Y5anpQiWLWJbtZxqyhRizVqsUb9tqbCrx4kyzDD-Bf940UF6A64dRNs_yOlPp6u1zvRX7yCnVU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2023691762</pqid></control><display><type>article</type><title>Substance P ameliorates tumor necrosis factor‐alpha‐induced endothelial cell dysfunction by regulating eNOS expression in vitro</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Piao, Jiyuan ; Hong, Hyun Sook ; Son, Youngsook</creator><creatorcontrib>Piao, Jiyuan ; Hong, Hyun Sook ; Son, Youngsook</creatorcontrib><description>Objective
The aim of this study was to explore the beneficial effects of SP on NO production and inflammation‐induced vascular endothelium cell death.
Methods
To mimic the inflammatory environment, TNF‐α was treated with HUVECs, and SP was added prior to TNF‐α to determine its protective effect. WST‐1 assay was performed to detect cell viability. NO level in conditioned medium was measured by Griess Reagent System. The protein level of cleaved caspase‐3, eNOS, and phosphorylated Akt was detected by Western blot analysis.
Results
TNF‐α declined endothelial cell viability by downregulating Akt and NO production. TNF‐α‐induced cell death was reliably restored by NO, confirming the requirement of NO for cell survival. By contrast, pretreatment of SP attenuated TNF‐α‐induced cellular apoptosis, accompanied by an increase in the phosphorylation of Akt, eNOS expression, and NO production. Blockage of NK‐1R, phosphorylated Akt or eNOS by CP‐96345, A6730, or L‐NAME entirely eliminated the effect of SP.
Conclusions
SP can protect the vascular endothelium against inflammation‐induced damage through modulation of the Akt/eNOS/NO signaling pathway.</description><identifier>ISSN: 1073-9688</identifier><identifier>EISSN: 1549-8719</identifier><identifier>DOI: 10.1111/micc.12443</identifier><identifier>PMID: 29412499</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Apoptosis ; Endothelium ; Endothelium, Vascular - drug effects ; Endothelium, Vascular - pathology ; Endothelium, Vascular - physiopathology ; Human Umbilical Vein Endothelial Cells ; Humans ; inflammation ; Inflammation - chemically induced ; Inflammation - drug therapy ; Necrosis ; Neurotransmitter Agents - therapeutic use ; nitric oxide ; Nitric Oxide - biosynthesis ; Nitric Oxide - metabolism ; Nitric Oxide Synthase Type III - drug effects ; Nitric Oxide Synthase Type III - metabolism ; Proto-Oncogene Proteins c-akt - metabolism ; Signal Transduction - drug effects ; substance P ; Substance P - pharmacology ; Substance P - therapeutic use ; Tumor Necrosis Factor-alpha - adverse effects ; Tumor necrosis factor-TNF ; vascular endothelium</subject><ispartof>Microcirculation (New York, N.Y. 1994), 2018-04, Vol.25 (3), p.e12443-n/a</ispartof><rights>2018 John Wiley & Sons Ltd</rights><rights>2018 John Wiley & Sons Ltd.</rights><rights>Copyright © 2018 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3573-4568c4e6b750ca68d2b11e69f95645967ff2fc82a05acf6aa47f7940f5b4ede43</citedby><cites>FETCH-LOGICAL-c3573-4568c4e6b750ca68d2b11e69f95645967ff2fc82a05acf6aa47f7940f5b4ede43</cites><orcidid>0000-0003-3659-1386 ; 0000-0003-1656-0056</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29412499$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Piao, Jiyuan</creatorcontrib><creatorcontrib>Hong, Hyun Sook</creatorcontrib><creatorcontrib>Son, Youngsook</creatorcontrib><title>Substance P ameliorates tumor necrosis factor‐alpha‐induced endothelial cell dysfunction by regulating eNOS expression in vitro</title><title>Microcirculation (New York, N.Y. 1994)</title><addtitle>Microcirculation</addtitle><description>Objective
The aim of this study was to explore the beneficial effects of SP on NO production and inflammation‐induced vascular endothelium cell death.
Methods
To mimic the inflammatory environment, TNF‐α was treated with HUVECs, and SP was added prior to TNF‐α to determine its protective effect. WST‐1 assay was performed to detect cell viability. NO level in conditioned medium was measured by Griess Reagent System. The protein level of cleaved caspase‐3, eNOS, and phosphorylated Akt was detected by Western blot analysis.
Results
TNF‐α declined endothelial cell viability by downregulating Akt and NO production. TNF‐α‐induced cell death was reliably restored by NO, confirming the requirement of NO for cell survival. By contrast, pretreatment of SP attenuated TNF‐α‐induced cellular apoptosis, accompanied by an increase in the phosphorylation of Akt, eNOS expression, and NO production. Blockage of NK‐1R, phosphorylated Akt or eNOS by CP‐96345, A6730, or L‐NAME entirely eliminated the effect of SP.
Conclusions
SP can protect the vascular endothelium against inflammation‐induced damage through modulation of the Akt/eNOS/NO signaling pathway.</description><subject>Apoptosis</subject><subject>Endothelium</subject><subject>Endothelium, Vascular - drug effects</subject><subject>Endothelium, Vascular - pathology</subject><subject>Endothelium, Vascular - physiopathology</subject><subject>Human Umbilical Vein Endothelial Cells</subject><subject>Humans</subject><subject>inflammation</subject><subject>Inflammation - chemically induced</subject><subject>Inflammation - drug therapy</subject><subject>Necrosis</subject><subject>Neurotransmitter Agents - therapeutic use</subject><subject>nitric oxide</subject><subject>Nitric Oxide - biosynthesis</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Synthase Type III - drug effects</subject><subject>Nitric Oxide Synthase Type III - metabolism</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>substance P</subject><subject>Substance P - pharmacology</subject><subject>Substance P - therapeutic use</subject><subject>Tumor Necrosis Factor-alpha - adverse effects</subject><subject>Tumor necrosis factor-TNF</subject><subject>vascular endothelium</subject><issn>1073-9688</issn><issn>1549-8719</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kc9uFDEMxiMEoqVw4QFQJC6o0pYkk8lMjmhFS6VCkQrnKJNx2lQzyZI_bfdWiRfgGXkSMmzhwAFfbMk_f7L9IfSSkiNa4-3sjDmijPPmEdqnLZervqPyca1J16yk6Ps99Cyla0JI3zP5FO0xySsv5T76flGGlLU3gD9jPcPkQtQZEs5lDhF7MDEkl7DVJof48_6HnjZXumbnx2JgxODHkK_qnJ6wgWnC4zbZ4k12weNhiyNclkln5y8xfDq_wHC3iZDS0nUe37gcw3P0xOopwYuHfIC-Hr__sv6wOjs_OV2_O1uZpq2H8Fb0hoMYupYYLfqRDZSCkFa2grdSdNYya3qmSauNFVrzznaSE9sOHEbgzQF6s9PdxPCtQMpqdmnZWXsIJSkqpaSSN6yp6Ot_0OtQoq_bKUZYIyTtBKvU4Y5anpQiWLWJbtZxqyhRizVqsUb9tqbCrx4kyzDD-Bf940UF6A64dRNs_yOlPp6u1zvRX7yCnVU</recordid><startdate>201804</startdate><enddate>201804</enddate><creator>Piao, Jiyuan</creator><creator>Hong, Hyun Sook</creator><creator>Son, Youngsook</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3659-1386</orcidid><orcidid>https://orcid.org/0000-0003-1656-0056</orcidid></search><sort><creationdate>201804</creationdate><title>Substance P ameliorates tumor necrosis factor‐alpha‐induced endothelial cell dysfunction by regulating eNOS expression in vitro</title><author>Piao, Jiyuan ; Hong, Hyun Sook ; Son, Youngsook</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3573-4568c4e6b750ca68d2b11e69f95645967ff2fc82a05acf6aa47f7940f5b4ede43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Apoptosis</topic><topic>Endothelium</topic><topic>Endothelium, Vascular - drug effects</topic><topic>Endothelium, Vascular - pathology</topic><topic>Endothelium, Vascular - physiopathology</topic><topic>Human Umbilical Vein Endothelial Cells</topic><topic>Humans</topic><topic>inflammation</topic><topic>Inflammation - chemically induced</topic><topic>Inflammation - drug therapy</topic><topic>Necrosis</topic><topic>Neurotransmitter Agents - therapeutic use</topic><topic>nitric oxide</topic><topic>Nitric Oxide - biosynthesis</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Synthase Type III - drug effects</topic><topic>Nitric Oxide Synthase Type III - metabolism</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>substance P</topic><topic>Substance P - pharmacology</topic><topic>Substance P - therapeutic use</topic><topic>Tumor Necrosis Factor-alpha - adverse effects</topic><topic>Tumor necrosis factor-TNF</topic><topic>vascular endothelium</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Piao, Jiyuan</creatorcontrib><creatorcontrib>Hong, Hyun Sook</creatorcontrib><creatorcontrib>Son, Youngsook</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Microcirculation (New York, N.Y. 1994)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Piao, Jiyuan</au><au>Hong, Hyun Sook</au><au>Son, Youngsook</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Substance P ameliorates tumor necrosis factor‐alpha‐induced endothelial cell dysfunction by regulating eNOS expression in vitro</atitle><jtitle>Microcirculation (New York, N.Y. 1994)</jtitle><addtitle>Microcirculation</addtitle><date>2018-04</date><risdate>2018</risdate><volume>25</volume><issue>3</issue><spage>e12443</spage><epage>n/a</epage><pages>e12443-n/a</pages><issn>1073-9688</issn><eissn>1549-8719</eissn><abstract>Objective
The aim of this study was to explore the beneficial effects of SP on NO production and inflammation‐induced vascular endothelium cell death.
Methods
To mimic the inflammatory environment, TNF‐α was treated with HUVECs, and SP was added prior to TNF‐α to determine its protective effect. WST‐1 assay was performed to detect cell viability. NO level in conditioned medium was measured by Griess Reagent System. The protein level of cleaved caspase‐3, eNOS, and phosphorylated Akt was detected by Western blot analysis.
Results
TNF‐α declined endothelial cell viability by downregulating Akt and NO production. TNF‐α‐induced cell death was reliably restored by NO, confirming the requirement of NO for cell survival. By contrast, pretreatment of SP attenuated TNF‐α‐induced cellular apoptosis, accompanied by an increase in the phosphorylation of Akt, eNOS expression, and NO production. Blockage of NK‐1R, phosphorylated Akt or eNOS by CP‐96345, A6730, or L‐NAME entirely eliminated the effect of SP.
Conclusions
SP can protect the vascular endothelium against inflammation‐induced damage through modulation of the Akt/eNOS/NO signaling pathway.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>29412499</pmid><doi>10.1111/micc.12443</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-3659-1386</orcidid><orcidid>https://orcid.org/0000-0003-1656-0056</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1073-9688 |
ispartof | Microcirculation (New York, N.Y. 1994), 2018-04, Vol.25 (3), p.e12443-n/a |
issn | 1073-9688 1549-8719 |
language | eng |
recordid | cdi_proquest_miscellaneous_1999194323 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Apoptosis Endothelium Endothelium, Vascular - drug effects Endothelium, Vascular - pathology Endothelium, Vascular - physiopathology Human Umbilical Vein Endothelial Cells Humans inflammation Inflammation - chemically induced Inflammation - drug therapy Necrosis Neurotransmitter Agents - therapeutic use nitric oxide Nitric Oxide - biosynthesis Nitric Oxide - metabolism Nitric Oxide Synthase Type III - drug effects Nitric Oxide Synthase Type III - metabolism Proto-Oncogene Proteins c-akt - metabolism Signal Transduction - drug effects substance P Substance P - pharmacology Substance P - therapeutic use Tumor Necrosis Factor-alpha - adverse effects Tumor necrosis factor-TNF vascular endothelium |
title | Substance P ameliorates tumor necrosis factor‐alpha‐induced endothelial cell dysfunction by regulating eNOS expression in vitro |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T01%3A16%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Substance%20P%20ameliorates%20tumor%20necrosis%20factor%E2%80%90alpha%E2%80%90induced%20endothelial%20cell%20dysfunction%20by%20regulating%20eNOS%20expression%20in%20vitro&rft.jtitle=Microcirculation%20(New%20York,%20N.Y.%201994)&rft.au=Piao,%20Jiyuan&rft.date=2018-04&rft.volume=25&rft.issue=3&rft.spage=e12443&rft.epage=n/a&rft.pages=e12443-n/a&rft.issn=1073-9688&rft.eissn=1549-8719&rft_id=info:doi/10.1111/micc.12443&rft_dat=%3Cproquest_cross%3E1999194323%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3573-4568c4e6b750ca68d2b11e69f95645967ff2fc82a05acf6aa47f7940f5b4ede43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2023691762&rft_id=info:pmid/29412499&rfr_iscdi=true |